Age differences in muscarinic cholinergic receptors assayed with (+)N-[11C]methyl-3-piperidyl benzilate in the brains of conscious monkeys

Synapse

Volumn 41, Issue 3, 2001, Pages 248-257

  Tsukada, Hideo ^a   Kakiuchi, Takeharu ^a   Nishiyama, Shingo ^a   Ohba, Hiroyuki ^a   Sato, Kengo ^a   Harada, Norihiro ^a   Takahashi, Kazuhiro ^b  

^a HAMAMATSU PHOTONICS K K   (Japan)

^b RESEARCH INSTITUTE FOR BRAIN AND BLOOD VESSELS AKITA   (Japan)

Author keywords

Aging; Cortisol; Monkey brain; Muscarinic receptor; N 11C methyl 3 piperidyl benzilate; PET

Indexed keywords

CARBON 11; HYDROCORTISONE; MEPENZOLATE; MEPENZOLATE C 11; MUSCARINIC RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; AGED; AGING; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CORPUS STRIATUM; FRONTAL CORTEX; HIPPOCAMPUS; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; KINETICS; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; TEMPORAL CORTEX;

AGING; ANIMALS; BENZILATES; BRAIN; CARBON RADIOISOTOPES; CONSCIOUSNESS; HALLUCINOGENS; HYDROCORTISONE; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MALE; RADIOLIGAND ASSAY; RECEPTORS, MUSCARINIC; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035452377     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.1082     Document Type: Article

References (57)

1. Kinetic evaluation of positron-emitting muscarinic receptor ligands employing direct intracarotid injection
2. Cholinergic function and intellectual decline in Alzheimer's disease
3. An approach for the study of specific binding in vivo using positron computed tomography
4. Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging
5. Three-dimensional stereotactic surface projection analysis of macaque brain PET: Development and initial applications
6. 11C]levetimide
7. 11C-methyl]benztropine
8. Age-related decrease in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET)
9. Alterations of brain neurotransmitter receptor binding in Huntington's chorea
10. High dosage anticholinergic therapy in dystonia
11. 2-dopamine receptors studied by PET - A comparison to the equilibrium analysis
12. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease
13. 11C]scopolamine and positron emission tomography
14. Basal forebrain cholinergic neurons and Alzheimer's disease
15. Cortical effects of scopolamine compared to Alzheimer's disease
16. Neuroreceptor assay with positron emission tomography; Equilibrium versus dynamic approach
17. 2A receptors: PET study in the conscious monkey brain
18. 11C](-)McN5652 in conscious monkeys
19. Alzheimer's disease
20. 11C]tropanyl benzilate binding to muscarinic cholinergic receptors: Methodology and kinetic modeling alterations
21. 11C]tropanyl benzilate
22. Studies on muscarinic binding sites in human brain identified with pirenzepine
23. 11C-methyl-(-)-cocaine PET studies in human subjects
24. Cholinergic neurotransmission studies in vivo using positron emission tomography or single photon emission computerized tomography
25. Adrenal steroid receptors and actions in the nervous system
26. Synthesis and regional brain distribution of [C-11]N-methyl-4-piperidyl benzilate ([C-11]NMPB) in the rat
27. 11C]formaldehyde
28. Synthesis, rodent biodistribution, dosimetry, metabolism and monkey images of carbon-11-labeled (+)-2α-tropanyl benzilate: A central muscarinic receptor imaging agent
29. LIGAND: A versatile computerized approach for the characterization of ligand binding systems
30. 11C]methy-4-piperidyl benzilate in the conscious monkey brains
31. 11C]methy-3-piperidyl benzilate in the conscious monkey brain
32. 11C- methylspiperone binding in vivo: Positron emission tomography study using conscious rhesus monkey
33. The cholinergic hypothesis - Ten years on
34. 11C]QNB
35. Muscarinic and dopaminergic receptors in the aging human brain
36. Muscarinic binding and choline acetyltransferase activity in parkinsonian subjects with reference to dementia
37. The attractions of proteins for small molecules and ions
38. Deciphering Alzheimer's disease: The amyloid precursor protein yields new clues
39. Human serial learning: Enhancement with arecoline and choline and impairment with scopolamine
40. Biochemical identification of the mammalian muscarinic cholinergic receptor
41. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography
42. 11C]3NMPB enantiomers in rats for studying muscarinic cholinergic receptors using PET
43. 11C]methyl-3-piperidyl benzilate as a potent radioligand for positron emission tomography
44. Cholinergic hyperactive and negative schizophrenic symptoms: A model of dopaminergic/cholinergic interactions in schizophrenia
45. 2 receptors in the rat brain: An in vivo study using positron emission tomography
46. 11C]raclopride?: PET studies combined with microdialysis in conscious monkeys
47. Isoflurane anesthesia enhances the inhibitory effects of cocaine and GBR12909 on dopamine transporter: PET studies in combination with microdialysis in the monkey brain
48. 11C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: Multi-parametric PET studies combined with microdialysis analysis
49. 2 receptor availability in vivo by regulating receptor affinity induced by facilitated synaptic dopamine turnover: PET studies with microdialysis in the conscious monkey brain
50. 11C]4-MPB
51. 11C]scopolamine: Synthesis and distribution in rat brain
52. Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey
53. Biochemical characterization of the muscarinic cholinergic receptor in human brain: Alterations in Huntington's disease
54. A high resolution animal PET scanner using compact PS-PMT detectors
55. Age-related changes in multiple neurotransmitter systems in the monkey brain
56. Inhibition action of E2020, a novel acetylcholinesterase inhibitor, on cholinesterase: Comparison with other inhibitors
57. 11C]NMPB and positron emission tomography: Method development and differentiation of tracer delivery from receptor binding